Reuters logo
BRIEF-Tonix Pharmaceuticals receives European patent for the active ingredient in Tonmya
September 14, 2017 / 8:32 PM / 2 months ago

BRIEF-Tonix Pharmaceuticals receives European patent for the active ingredient in Tonmya

Sept 15 (Reuters) - Tonix Pharmaceuticals Holding Corp

* Tonix Pharmaceuticals receives European patent for the active ingredient in Tonmya® (cyclobenzaprine hcl sublingual tablets) Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below